Recent 13F filings as of December 2025 show that 176 institutional investors hold a position in Anavex Life Sciences Corp. (NASDAQ:AVXL).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 7,526,130 | 337,861 | 4.70% | $26,793,024.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 5,028,534 | -75,976 | -1.49% | $17,901,581.00 |
| STATE STREET CORP | 31 Dec, 2025 | 4,383,406 | 1,096,288 | 33.35% | $15,604,925.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,022,912 | -4,415 | -0.22% | $7,202,868.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,653,696 | 616,742 | 59.48% | $5,887,158.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,209,570 | 451,070 | 59.47% | $4,306,069.00 |
| Summit Financial, LLC | 31 Dec, 2025 | 903,392 | 459,121 | 103.34% | $3,216,076.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 872,968 | 569,579 | 187.74% | $3,107,766.00 |
| NWAM LLC | 31 Dec, 2025 | 870,796 | -3,487 | -0.40% | $4,371,395.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 860,155 | 552,138 | 179.26% | $3,062,152.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 738,242 | -34,770 | -4.50% | $2,628,142.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 668,956 | -48,422 | -6.75% | $2,381,483.00 |
| LPL Financial LLC | 31 Dec, 2025 | 528,782 | -5,537 | -1.04% | $1,882,464.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 524,189 | 353,303 | 206.75% | $1,866,112.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 493,172 | 231,892 | 88.75% | $1,755,693.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 474,856 | -85,292 | -15.23% | $1,690,488.00 |
| UBS Group AG | 31 Dec, 2025 | 459,394 | -32,583 | -6.62% | $1,635,443.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 439,499 | -164,319 | -27.21% | $1,564,616.00 |
| Private Advisor Group, LLC | 31 Dec, 2025 | 419,800 | -35,325 | -7.76% | $1,494,488.00 |
| Caption Management, LLC | 31 Dec, 2025 | 414,838 | 354,838 | 591.40% | $1,476,823.00 |